Project Grant HT9425261E038
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- Federal Project Grant Award Summary The University of California, San Diego received a $1,197,813 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on August 15, 2025, with a completion date of August 14, 2028. The award supports research focused on mechanism dissection and model development of human PD1 (Programmed Death receptor 1) in melanoma. This three-year initiative will be conducted at UC San Diego's La...
- Federal Project Grant Award Summary The University of California, San Diego (UCSD) received a $1,197,884 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded August 15, 2025, with a completion date of August 14, 2028. The award supports research focused on mechanism dissection and model development of human PD1 (Programmed Death receptor 1) in melanoma. This funding enables UCSD to conduct biomedical research...
- The University of California, San Diego (UC San Diego) was awarded a $592,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 1, 2025, supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of California, San Diego (UCSD) was awarded a $592,500.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy." The award, which spans from February 1, 2025 to January 31, 2028, aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UCSD, a...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.97M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports the development of CD46-targeted antibody fragment radiopharmaceutical therapy for prostate cancer treatment. This research initiative represents a translational medicine effort to advance diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $750,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective March 1, 2026 through February 28, 2029. The award supports research on the use of dimeric immunoglobulin A (dIgA) as a therapeutic approach to treat breast cancer. This three-year research initiative is being conducted at UCSF's San Francisco...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded on September 30, 2025, with a completion date of September 29, 2029. The award supports research to validate CD46 as a promising biomarker in advanced prostate cancer. This research aligns with the program's mission to advance biomedical innovation for...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2029. The grant supports advanced biomedical research investigating the canonical Polycomb repressive complex 1 (CPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This...
- Federal Grant Award Summary UCLA's Office of Research Administration received a $235,476 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning November 1, 2025, with a completion date of October 31, 2027. The award supports the development of new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer, a specialized cancer research initiative aligned with the Defense Health Agency's mission to...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,594,419 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research focused on developing innovative diagnostic and...